These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2713165)

  • 1. HIV-1 core proteins expressed from recombinant vaccinia viruses.
    Rautmann G; Kieny MP; Brandely R; Dott K; Girard M; Montagnier L; Lecocq JP
    AIDS Res Hum Retroviruses; 1989 Apr; 5(2):147-57. PubMed ID: 2713165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to conserved regions of the major core protein (gag24) of HIV-1 and HIV-2.
    Carpio E; Duarte C; Hinkula J; Broliden PA; Rosén J; Campal A; Gavilondo J; Wahren B; Jondal M
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):97-101. PubMed ID: 1707645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly immunogenic human immunodeficiency viruslike particles are produced by recombinant vaccinia virus-infected cells.
    Vzorov AN; Bukrinsky MI; Grigoriev VB; Tentsov YYu ; Bukrinskaya AG
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):29-36. PubMed ID: 1901721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice.
    Wild TF; Bernard A; Spehner D; Drillien R
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():359-67. PubMed ID: 1538193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
    Gómez CE; Nájera JL; Jiménez V; Bieler K; Wild J; Kostic L; Heidari S; Chen M; Frachette MJ; Pantaleo G; Wolf H; Liljeström P; Wagner R; Esteban M
    Vaccine; 2007 Mar; 25(11):1969-92. PubMed ID: 17224219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeast-expressed p55 precursor core protein of human immunodeficiency virus type 1 does not elicit protective immunity in chimpanzees.
    Emini EA; Schleif WA; Quintero JC; Conard PG; Eichberg JW; Vlasuk GP; Lehman ED; Polokoff MA; Schaeffer TF; Schultz LD
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1247-50. PubMed ID: 2127681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.
    Ramakrishna L; Anand KK; Mohankumar KM; Ranga U
    J Virol; 2004 Sep; 78(17):9174-89. PubMed ID: 15308713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cloning and expression in Escherichia coli of sequences coding for p24, the core protein of human immunodeficiency virus, and the use of the recombinant protein in characterizing a panel of monoclonal antibodies against the viral p24 protein.
    Spence RP; Jarvill WM; Ferns RB; Tedder RS; Parker D
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2843-51. PubMed ID: 2479710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethality in mice infected with recombinant vaccinia virus expressing hepatitis C virus core protein.
    Zhang H
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):374-82. PubMed ID: 14599943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus.
    Hu SL; Travis BM; Garrigues J; Zarling JM; Sridhar P; Dykers T; Eichberg JW; Alpers C
    Virology; 1990 Nov; 179(1):321-9. PubMed ID: 2219727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of immunogenic HIV-1 viruslike particles in stably engineered monkey cell lines.
    Haynes JR; Cao SX; Rovinski B; Sia C; James O; Dekaban GA; Klein MH
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):17-27. PubMed ID: 1707639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to viral infection by intraepithelial lymphocytes in HIV-1 P18-I10-specific T-cell receptor transgenic mice.
    Kuribayashi H; Wakabayashi A; Shimizu M; Kaneko H; Norose Y; Nakagawa Y; Wang J; Kumagai Y; Margulies DH; Takahashi H
    Biochem Biophys Res Commun; 2004 Apr; 316(2):356-63. PubMed ID: 15020225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and characterization of HIV-1 Gag p17-p24 protein].
    Li TY; Jin NY; Wang HW; Guo ZR; Fang HH; An RG; Yin Z
    Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):65-8. PubMed ID: 10883279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
    Calarota SA; Kjerrström A; Islam KB; Wahren B
    Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major antigenic domain recognized by monoclonal antibodies maps within the carboxy-terminal moiety of a recombinant human immunodeficiency virus-1 p24 protein.
    Gallina A; Rossi F; Mariani M; Bonelli F; Achilli G; Cattaneo E; Milanesi G
    J Med Virol; 1990 Nov; 32(3):164-70. PubMed ID: 1704049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses.
    Liniger M; Zuniga A; Morin TN; Combardiere B; Marty R; Wiegand M; Ilter O; Knuchel M; Naim HY
    Vaccine; 2009 May; 27(25-26):3299-305. PubMed ID: 19200842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
    Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.